Aktie A243070 HUONS CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Huons Co., Ltd.

Aktien

A243070

KR7243070000

A243070

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 24.04.2024 		% 5 Tage % 1. Jan.
34.400 KRW +0,29 % Intraday Chart für Huons Co., Ltd. +2,53 % -10,42 %
20.03. Huons Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Huons Co. Ltd. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
South Korea's Huons to Export Anesthetics to Canada
GenEdit Inc. amended terms of the transaction
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant
GenEdit Inc. announced that it expects to receive $30 million in funding
Haemato : to Seek EU Approval for Botox Product
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A243070 Aktie
  4. Nachrichten Huons Co., Ltd.
  5. Andere Sprachen